Funded Tech Companies
Syntax Bio
Headquartered in Chicago, Syntax Bio has funding from Astellas Venture Capital, Illumina Ventures and Civilization Ventures.
Company Overview
Company Name
Syntax Bio
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
400 N Aberdeen, 9th Floor 9
Chicago, IL 60642
USA
Chicago, IL 60642
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Syntax Bio is a preclinical-stage biotech company overcoming the longstanding challenges in stem cell-derived therapies by directly controlling and accelerating cell differentiation. Our Cellgorithm technology provides control over the complex developmental biology needed to manufacture stem cell-derived cell therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/18/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Flavin
Chief Technical Officer
Ryan Clarke
Co-Founder
Niko Balanis
Co-Founder
Brad Merrill
VP - Sales
Nick Timmins
Company Investors
- Astellas Venture Capital
- Illumina Ventures
- Civilization Ventures
- EGB Ventures
- DCVC Bio
- Portal Innovations
Browse more funded tech companies:
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs